Evidence map›Paper›PMID 42032379›Full record

ArticleJournal of computer-aided molecular design2026

Quantifying conformational diversity in protein-ligand ensembles for structure-based virtual screening.

Pei Kun Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pei Kun Yang, Independent Researcher, Taiwan. peikun@isu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structure-based virtual screening (SBVS) requires accurate representations of protein and ligand conformational states, since both components can adopt diverse geometries that influence binding energetics. Using 79 HIV-1 protease-ligand complexes, we quantify how conformational heterogeneity and ensemble clustering shape the evaluation of interaction energies by comparing native complexes, nonnative pairings, protein ensembles derived from apo MD, and ligand ensembles sampled in solution. Native complexes consistently yield favorable interactions, whereas nonnative pairings are rarely favorable and often highly unfavorable, indicating that many failures in screening that uses a single structure arise from protein-ligand geometric mismatch rather than from the scoring function alone. We further show that structural reduction of protein and ligand ensembles decreases the recovery of favorable interaction states, and that simultaneous reduction of both ensembles constrains the availability of complementary structural pairs. Because SBVS is often limited by computational cost, receptor ensembles are typically restricted to a small number of conformations. Here, we quantify the sampling scale and the level of ensemble reduction required to retain binding-compatible geometries and stable interaction-energy trends, providing practical guidance for ensemble-based screening.

Indexed as

HIV-1HIV ProteaseHIV Protease InhibitorsBinding SitesHumansLigandsMolecular Dynamics SimulationProtein BindingProtein ConformationThermodynamicsHIV ProteaseHIV Protease InhibitorsLigandsp16 protease, Human immunodeficiency virus 1Binding EnergeticsConformational SamplingEnsemble DockingLigand Conformational EnsemblesProtein FlexibilityRMSD Clustering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.